×

Growth Reports

Growth Reports
Report Name

Non Invasive Prenatal Testing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Gestation Period (0 to 12 Weeks, 13 to 24 Weeks, 25 to 36 Weeks), By Pregnancy Risk (High & Average Risk, Low Risk), By Method (Ultrasound Detection, Biochemical Screening Tests, Cell-Free DNA in Maternal Plasma Tests), By Technology (NGS, Array Technology, PCR, Others), By Product (Consumables & Reagents, Instruments), By Application (Trisomy, Microdeletion Syndrome, Others), By End-user (Hospitals & Clinics, Diagnostic Laboratories), Countries and Companies Report

Non Invasive Prenatal Testing Market is projected to register a 13.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003801  |   No. of Pages: 201

Infectious Disease In Vitro Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Instruments, Reagents, Software Services), By Technology (Immunoassay, Molecular Diagnostics, Microbiology), By Application (MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others), By Test Location (Point of Care, Central Laboratories, Others), Countries and Companies Report

Infectious Disease In Vitro Diagnostics Market is projected to register a 3.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003800  |   No. of Pages: 190

Infectious Respiratory Disease Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Instruments, Consumables, Services), By Sample Type (Saliva, Nasopharyngeal Swabs (NPS), Anterior Nasal Region, Blood, Others), By Application (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Tuberculosis, Streptococcus Testing, Others), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), By End-User (Hospitals, Diagnostic Laboratories, Physician Offices, Others), Countries and Companies Report

Infectious Respiratory Disease Diagnostics Market is projected to register a 2.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003799  |   No. of Pages: 195

Cellular Health Screening Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Test (Single Test Panels, Multi-test Panels), By Sample Type (Blood, Saliva, Serum, Urine), By Collection Site (Home, Office, Hospital, Diagnostic Labs, Others), Countries and Companies Report

Cellular Health Screening is projected to register a 10.6% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD0003798  |   No. of Pages: 205

Monkeypox Testing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Technology (Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Others), By End-user (Hospitals and Clinics, Diagnostic Laboratories, Others), Countries and Companies Report

Monkeypox Testing Market is projected to register a 4.6% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003797  |   No. of Pages: 210

Proteinase K Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Form (Powder, Liquid), By Therapeutic Area (Infectious diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases, Neurology, Others), By Application (Isolation and purification of genomic DNA & RNA, In situ hybridization, Mitochondria isolation), By End-user (Contract research organization, Academic institutes, Biotechnology companies, Diagnostic laboratories), Countries and Companies Report

Proteinase K Market is projected to register a 6.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003796  |   No. of Pages: 189

Nucleic Acid Amplification Testing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Polymerase Chain Reaction (PCR) tests, Isothermal Nucleic Acid Amplification Technology (INAAT) tests, Ligase Chain Reaction (LCR) tests), By Application (Infectious disease testing , Oncology testing, Genetic & mitochondrial disease testing, Others), By End-user (Hospitals, Central and reference laboratories, Others), Countries and Companies Report

Nucleic Acid Amplification Testing Market is projected to register a 10.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003794  |   No. of Pages: 193

Cancer Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Consumables, Instruments, Biopsy Instruments), By Technology (IVD Testing, Imaging, Biopsy Technique), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Others), By End-User (Hospitals, Diagnostic Laboratories), Countries and Companies Report

Cancer Diagnostics is projected to register a 8.9% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD0003793  |   No. of Pages: 205

Gastrointestinal Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Test Type, Endoscopy, Blood test, H. pylori test, Calprotectin test, Immunoglobulin A test, Others), By Technology (ELISA, PCR, Microbiology, Others), By Application (Infection, Inflammatory Bowel Disease, Gastroesophageal Reflux Disease (GERD), Cancer, Others), By Test Location (Central laboratories, Point-of-Care), Countries and Companies Report

Gastrointestinal Diagnostics Market is projected to register a 4.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003792  |   No. of Pages: 203

Urinalysis Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Instrument (Biochemical urine analyzers, Automated urine sediment analyzers, Point-of-care urine analyzers), By Consumables (Dipsticks, Reagents, Disposables, Pregnancy and fertility kits), By Application (Disease Screening, Pregnancy and Fertility Testing), By End-user (Hospitals, Clinical Laboratories, Home Care, Research and Academics, Others), Countries and Companies Report

Urinalysis Market is projected to register a 7.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003791  |   No. of Pages: 202

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us